Aemetis Inc (NASDAQ:AMTX) Could Improve Your Long Portfolio After Less Shorts Reported

May 16, 2018 - By Peter Erickson

Aemetis, Inc. (NASDAQ:AMTX) Logo

The stock of Aemetis Inc (NASDAQ:AMTX) registered a decrease of 25.77% in short interest. AMTX’s total short interest was 258,400 shares in May as published by FINRA. Its down 25.77% from 348,100 shares, reported previously. With 107,500 shares average volume, it will take short sellers 2 days to cover their AMTX’s short positions. The short interest to Aemetis Inc’s float is 1.8%.

The stock decreased 1.12% or $0.02 during the last trading session, reaching $1.77. About 8,432 shares traded. Aemetis, Inc. (NASDAQ:AMTX) has risen 78.07% since May 16, 2017 and is uptrending. It has outperformed by 66.52% the S&P500.

Aemetis, Inc. operates as an international renewable fuels and bio-chemicals firm in North America and India. The company has market cap of $35.80 million. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries. It currently has negative earnings. The firm owns and operates a biodiesel plant in Kakinada, India; and an ethanol plant in Keyes, California.

More important recent Aemetis, Inc. (NASDAQ:AMTX) news were published by: Seekingalpha.com which released: “Aemetis’ (AMTX) CEO Eric McAfee on Q1 2018 Results – Earnings Call Transcript” on May 13, 2018, also Globenewswire.com published article titled: “Aemetis to Review First Quarter Financial Results on May 10, 2018”, Nasdaq.com published: “Aemetis CEO to Present at the Disruptive Growth & Healthcare Conference on May 9th” on May 03, 2018. More interesting news about Aemetis, Inc. (NASDAQ:AMTX) was released by: Nasdaq.com and their article: “Upgraded Aemetis Plant in India Completes Biodiesel Production Using Lower Cost, High FFA Waste Feedstock” with publication date: April 25, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.